13F

Stock

C4 Therapeutics, Inc.

CCCC · held by 6 managers

Reported value

$15.8M

Holders

6

+1 new · −1 exited

Holders’ est. mark

$53.8K

Price effect on 2 books still in the name

Largest holder

$11M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY4.97M$11MHeld
BANK OF AMERICA CORP /DE/2.05M$4.56MHeld
BARCLAYS PLC43.1K$95.6K$34KAdded$30.1K
FARALLON CAPITAL MANAGEMENT LLC28K$62.2KNew
Cresset Asset Management, LLC25K$55.5K$19.8KAdded$19.8K
IFP Advisors, Inc17$38Held

Who left

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.